In this mutation sequence, the BAP1 mutation has been assumed to occur relatively late in tumor progression, preceded by oncogenic mutations in G-protein subunits including GNA11 and GNAQ that are present in as high as 83–96% of UM7. The gene discussed is GNA11; the disease is neoplasm.